RNA has released its 2025 Q4 earnings report, with revenue of 859.00K, reflecting a YoY change of -71.11%, and net profit of -29.14M, showing a YoY change of -153.09%. The Sankey diagram below clearly presents RNA's revenue sources and cost distribution.

Atrium Therapeutics (RNA) key financial stats and ratios, covering profitability, financial health, and leverage.

Atrium Therapeutics (RNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Atrium Therapeutics (RNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Atrium Therapeutics (RNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Where does Atrium Therapeutics (RNA) generate its revenue? Explore its key revenue streams and top earning regions.